Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Intervalo de año de publicación
1.
J Fr Ophtalmol ; 44(7): 977-980, 2021 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-34147273

RESUMEN

PURPOSE: To describe the management of an iris stromal cyst by fine needle aspiration and irrigation with absolute alcohol to induce cyst sclerosis. METHODS: We present the case of a 45-year-old patient with no previous history referred for a 3-month history of an iris lesion in his right eye. Examination revealed a 2.1×3mm cyst with transparent walls at the right inferonasal iris root, and a primary acquired iris stromal cyst was diagnosed. Initially, observation was recommended, but at the 2-month follow-up, growth of the lesion was observed, so fine needle aspiration and cryotherapy were performed, with recurrence after 2 months. Subsequently, fine needle aspiration and irrigation with absolute alcohol for 2minutes to induce sclerosis of the cyst was carried out. Two weeks after surgery, argon laser was performed on the iris root and remaining walls of the cyst to induce adherence. RESULTS: After 1 year of the procedure, the patient remains asymptomatic, without associated complications. A depression and hyperpigmentation of the iris in the inferonasal sector persists, without recurrence of internal fluid or increase in cyst volume. Endothelial cell count and intraocular pressure monitoring have remained stable. CONCLUSION: Iris stromal cyst sclerosis by aspiration and irrigation with absolute alcohol was effective and avoided complications associated with resection of the lesion.


Asunto(s)
Quistes , Enfermedades del Iris , Argón , Biopsia con Aguja Fina , Quistes/etiología , Quistes/cirugía , Etanol , Humanos , Iris/patología , Enfermedades del Iris/diagnóstico , Enfermedades del Iris/etiología , Enfermedades del Iris/terapia , Coagulación con Láser , Rayos Láser , Persona de Mediana Edad , Recurrencia Local de Neoplasia , Esclerosis
2.
Arch Soc Esp Oftalmol ; 82(6): 377-80, 2007 Jun.
Artículo en Español | MEDLINE | ID: mdl-17573650

RESUMEN

OBJECTIVE: To ascertain the efficacy of idebenone and multivitamin treatment in Leber's hereditary optic neuropathy (LHON). METHOD: Two patients diagnosed of unilateral LHON were treated with megadoses of idebenone, vitamin C and riboflavin for one year. They were examined clinically before, during and after treatment. RESULTS: No improvement of visual function was observed. Despite the idebenone treatment, in both cases the second eye became involved. CONCLUSIONS: Despite previous reports of visual recovery with idebenone in patients with LHON, our experience shows that an effective treatment for Leber's disease remains to be found.


Asunto(s)
Antioxidantes/uso terapéutico , Ácido Ascórbico/uso terapéutico , Benzoquinonas/uso terapéutico , Atrofia Óptica Hereditaria de Leber/tratamiento farmacológico , Riboflavina/uso terapéutico , Complejo Vitamínico B/uso terapéutico , Vitaminas/uso terapéutico , Adulto , Femenino , Humanos , Masculino , Insuficiencia del Tratamiento , Ubiquinona/análogos & derivados
3.
Arch. Soc. Esp. Oftalmol ; 82(6): 377-380, jun. 2007. ilus
Artículo en Es | IBECS | ID: ibc-055424

RESUMEN

Objetivo: Determinar la eficacia del tratamiento con idebenona y multivitamínico en la neuropatía óptica hereditaria de Leber (NOHL). Método: Dos pacientes diagnosticados de NOHL, fueron tratados con idebenona, vitamina C y riboflavina durante un año. Ambos fueron evaluados clínicamente antes, durante y después del tratamiento. Resultado: Ninguno de los dos pacientes experimentó mejoría visual y ambos sufrieron afectación en el segundo ojo. Conclusiones: A pesar de casos publicados en la literatura de recuperación visual con idebenona en pacientes con NOHL, nuestra experiencia indica que este tratamiento no es efectivo para la enfermedad de Leber


Objective: To ascertain the efficacy of idebenone and multivitamin treatment in Leber’s hereditary optic neuropathy (LHON). Method: Two patients diagnosed of unilateral LHON were treated with megadoses of idebenone, vitamin C and riboflavin for one year. They were examined clinically before, during and after treatment. Results: No improvement of visual function was observed. Despite the idebenone treatment, in both cases the second eye became involved. Conclusions: Despite previous reports of visual recovery with idebenone in patients with LHON, our experience shows that an effective treatment for Leber’s disease remains to be found


Asunto(s)
Masculino , Femenino , Adulto , Humanos , Benzoquinonas/administración & dosificación , Enfermedades del Nervio Óptico/diagnóstico , Enfermedades del Nervio Óptico/tratamiento farmacológico , Atrofia Óptica Hereditaria de Leber/complicaciones , Atrofia Óptica Hereditaria de Leber/diagnóstico , Atrofia Óptica/complicaciones , Atrofia Óptica/diagnóstico , Riboflavina/uso terapéutico , Quimioterapia Combinada , Benzoquinonas/uso terapéutico , Atrofia Óptica Hereditaria de Leber/tratamiento farmacológico , Ácido Ascórbico/uso terapéutico , Atrofia Óptica/tratamiento farmacológico , Atrofia Óptica/epidemiología , Atrofia Óptica/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA